Lax and corrupt – Indian Dr assesses clinical trials

By Nick Taylor

- Last updated on GMT

Related tags: Clinical trials, India

An Indian doctor has slammed the nation’s clinical trials, claiming they use the vulnerable, the system is corrupt and that the country lacks high quality scientists.

The criticisms were made by Dr Amar Jesani in a short-film produced by Dutch non-governmental organisation Wemos. Jesani is a founding member of journals and research centres focused on medical ethics in India and has contributed in government committees on health.

India’s clinical trials came under increasing pressure last year following reports of infant deaths and Jesani’s comments show that some are still deeply uneasy about the current system.

The view held by Jesani, which echoes many who spoke out last year about the infant deaths, is that some drug companies are “compromising science and ethics in the pursuit of profit​” and that flaws in the Indian system allow this.

Jesani said: “Unfortunately in my country there are laws but they are not very well implemented so the regulation over the trials, the oversight mechanism, the functioning of the ethics committee and the Drug Controller General of India all of them are so lax that it makes India a big destination for clinical trials​.

They don’t have good scientists; they don’t have enough inspectors to go all over the county. The worst thing in every developing country is corruption. There is too much corruption​.”

One consequence of this is that clinical trials use the “desperate​” and “most vulnerable​” members if Indian society, according to Jesani. This alleged exploitation of India’s poor is what Jesani cites as bothering him most about the current system.

Jesani is a founder member of the Indian Journal of Medical Ethics (IJME), the Centre for Studies in Ethics and Rights (CSER) and the Centre for Enquiry into Health and Allied Themes (CEHAT).

The short-film can be viewed here​.

Related news

Show more

Related products

show more

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

Syne Qua Non Clinical | 16-May-2018 | Business Advice

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars